Exodus Point Capital Management, LP Kymera Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$13.9 - $23.88 $2.42 Million - $4.16 Million	-174,308 Reduced 93.95%	11,217 $156,000
Q2 2023 Aug 10, 2023	BUY	$22.4 - $34.92 $4.16 Million - $6.48 Million	185,525 New	185,525 $4.27 Million
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $450,652 - $738,587	21,552 New	21,552 $469,000
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $448,249 - $1.4 Million	-15,969 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $416,790 - $531,448	15,969 New	15,969 $516,000

181

64.3M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.11B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.